Marker Therapeutics MRKR
$ 3.14
-1.26%
Quarterly report 2024-Q3
added 11-14-2024
Marker Therapeutics Cash Flow 2011-2024 | MRKR
Annual Cash Flow Marker Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-27 M | -27.3 M | -20 M | -18.3 M | -14.5 M | -8.44 M | -6.51 M | -4.34 M | -2.19 M | -695 K | -1.59 M | -1.31 M |
Depreciation & Amortization |
2.79 M | 2.15 M | 486 K | 105 K | - | - | - | - | - | - | - | - |
Accounts Payables |
1.61 M | 5.14 M | 2.94 M | 993 K | 1.62 M | 1.02 M | 680 K | - | - | - | - | - |
Accounts Receivables |
- | - | - | 56.2 K | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Marker Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -3.84 M | - | - | - | -5.89 M | - | -20.7 M | -13 M | -12.2 M | - | -22.4 M | -14.9 M | -8.1 M | - | -14.5 M | -8.4 M | -4.1 M | - | -13.7 M | -8.06 M | -3.88 M | - | -8.32 M | -4.75 M | -2.35 M | - | -5.96 M | -3.94 M | -1.92 M | - | -4.76 M | - | -830 K | - | - | -1.83 M | -1.01 M | - | -1.52 M | -611 K | -373 K | - | -755 K | -620 K | -17.5 M | - | -1.1 M | -824 K | -332 K | - | -877 K | -735 K | -404 K |
Depreciation & Amortization |
- | - | - | - | - | - | 818 K | - | 1.98 M | 1.16 M | 576 K | - | 1.58 M | 1.03 M | 503 K | - | 273 K | 125 K | 35.3 K | - | 70.9 K | 39.8 K | 10.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 213 K | - | - | - | - | - | - | - | - |
Accounts Payables |
1.9 M | 1.08 M | 1.2 M | 961 K | 1.16 M | 1.33 M | 2.86 M | 1.1 M | 2.02 M | 1.77 M | 5.02 M | 5.14 M | 2.33 M | 2.04 M | 1.89 M | 2.94 M | 2.94 M | 2.94 M | 2.94 M | 993 K | 993 K | 993 K | 993 K | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 1.02 M | - | - | 688 K | 680 K | - | - | 680 K | 691 K | - | - | - | 693 K | 671 K | - | - | 3.78 M | 3.78 M | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 559 | 135 | 3.44 K | 24.6 K | 56.2 K | 56.2 K | 56.2 K | 56.2 K | 108 K | 108 K | 108 K | 108 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency